Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

Cases of colorectal cancer have been rapidly increasing among young adults, so we spoke to a doctor to get some helpful tips.

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

The Health Promotion Administration (HPA) is to increase public funding for painless colonoscopy screenings for high-risk ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Expanded eligibility criteria and new tests for national cancer screening programs are to be introduced on Wednesday next ...

Colorectal cancer (CRC) is the third most common cancer globally, with more than 1.9 million new cases reported in 2020, according to World Cancer Research Fund. The US Preventive Services Task Force ...

The World Health Organization estimates that around 900,000 people each year die of colorectal cancer (CRC ... and studies suggest that CEA screening lacks sensitivity, missing about half ...

Improvements in cancer prevention and screening have averted more deaths than treatment advances over the past 45 years.

With colon cancer rates rising, advocates hope a newly approved blood test screening can help more people catch it early. “If we find it early, we have a lot more options in treating it,” said Dr.

to support commercialization of Mainz Biomed’s NextGen screening test for colorectal cancer. Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal cancer tumor DNA to aid ...